{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:26:03Z","timestamp":1791861963851,"version":"4.3.4"},"reference-count":94,"publisher":"Elsevier BV","issue":"13-14","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.addr.2008.06.002","type":"journal-article","created":{"date-parts":[[2008,7,7]],"date-time":"2008-07-07T16:01:26Z","timestamp":1215446486000},"page":"1527-1533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":563,"title":["Monoamine oxidase inactivation: From pathophysiology to therapeutics"],"prefix":"10.1016","volume":"60","author":[{"given":"Marco","family":"Bortolato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean C.","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2008.06.002_bib1","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/0006-2952(68)90066-X","article-title":"Some observations upon a new inhibitor of monoamine oxidase in brain tissue","volume":"17","author":"Johnston","year":"1968","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.addr.2008.06.002_bib2","first-page":"393","article-title":"Some puzzling pharmacological effects of monoamine oxidase inhibitors","volume":"5","author":"Knoll","year":"1972","journal-title":"Adv. Biochem. Psychopharmacol."},{"key":"10.1016\/j.addr.2008.06.002_bib3","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1073\/pnas.85.13.4934","article-title":"cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties","volume":"85","author":"Bach","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.addr.2008.06.002_bib4","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/0888-7543(89)90279-6","article-title":"Human monoamine oxidase A and B genes map to Xp 11.23 and are deleted in a patient with Norrie disease","volume":"4","author":"Lan","year":"1989","journal-title":"Genomics"},{"key":"10.1016\/j.addr.2008.06.002_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-7091-6499-0_1","article-title":"Determination of regions important for monoamine oxidase (MAO) a and b substrate and inhibitor selectivities","volume":"52","author":"Shih","year":"1998","journal-title":"J. Neural Transm., Suppl."},{"key":"10.1016\/j.addr.2008.06.002_bib6","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/jb\/118.5.974","article-title":"Regions of the molecule responsible for substrate specificity of monoamine oxidase A and B: a chimeric enzyme analysis","volume":"118","author":"Tsugeno","year":"1995","journal-title":"J. Biochem."},{"key":"10.1016\/j.addr.2008.06.002_bib7","doi-asserted-by":"crossref","first-page":"29499","DOI":"10.1074\/jbc.M100431200","article-title":"Effects of carboxyl-terminal truncations on the activity and solubility of human monoamine oxidase B","volume":"276","author":"Rebrin","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2008.06.002_bib8","doi-asserted-by":"crossref","first-page":"9877","DOI":"10.1074\/jbc.M006972200","article-title":"Substrate and inhibitor specificities for human monoamine oxidase A and B are influenced by a single amino acid","volume":"276","author":"Geha","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2008.06.002_bib9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1107\/S0907444903025770","article-title":"Crystallization and preliminary crystallographic analysis of rat monoamine oxidase A complexed with clorgyline","volume":"60","author":"Ma","year":"2004","journal-title":"Acta Crystallogr., D Biol. Crystallogr."},{"key":"10.1016\/j.addr.2008.06.002_bib10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jmb.2004.02.032","article-title":"Structure of rat monoamine oxidase A and its specific recognitions for substrates and inhibitors","volume":"338","author":"Ma","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.addr.2008.06.002_bib11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nsb732","article-title":"Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders","volume":"9","author":"Binda","year":"2002","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.addr.2008.06.002_bib12","doi-asserted-by":"crossref","first-page":"22222","DOI":"10.1074\/jbc.M202844200","article-title":"Activation of human monoamine oxidase B gene expression by a protein kinase C MAPK signal transduction pathway involves junc-jun and egr-1","volume":"277","author":"Wong","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2008.06.002_bib13","doi-asserted-by":"crossref","first-page":"36227","DOI":"10.1074\/jbc.M305549200","article-title":"Decreased methylation and transcription repressor Sp3 up-regulated human monoamine oxidase (MAO) B expression during Caco-2 differentiation","volume":"278","author":"Wong","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2008.06.002_bib14","doi-asserted-by":"crossref","first-page":"21021","DOI":"10.1074\/jbc.M312638200","article-title":"Dual functions of transcription factors, transforming growth factor-beta-inducible early gene (TIEG)2 and Sp3, are mediated by caccc element and Sp1 sites of human monoamine oxidase (MAO) B gene","volume":"279","author":"Ou","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2008.06.002_bib15","doi-asserted-by":"crossref","first-page":"21512","DOI":"10.1074\/jbc.M600250200","article-title":"Glucocorticoid and androgen activation of monoamine oxidase A are regulated differently by R1 and Sp1","volume":"281","author":"Ou","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2008.06.002_bib16","doi-asserted-by":"crossref","first-page":"10923","DOI":"10.1073\/pnas.0601515103","article-title":"Monoamine oxidase A and repressor R1 are involved in apoptotic signaling pathway","volume":"103","author":"Ou","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2008.06.002_bib17","doi-asserted-by":"crossref","first-page":"11552","DOI":"10.1074\/jbc.M410033200","article-title":"R1, a novel repressor of the human monoamine oxidase A","volume":"280","author":"Chen","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2008.06.002_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.neuro.22.1.197","article-title":"Monoamine oxidase: from genes to behavior","volume":"22","author":"Shih","year":"1999","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.addr.2008.06.002_bib19","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/j.1471-4159.1990.tb03121.x","article-title":"Tissue distribution of human monoamine oxidase A and B mRNA","volume":"55","author":"Grimsby","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.addr.2008.06.002_bib20","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0021-5198(19)52797-4","article-title":"Further studies on the synthesis of A-form monoamine oxidase","volume":"31","author":"Egashira","year":"1981","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.addr.2008.06.002_bib21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0009-8981(77)90039-0","article-title":"Properties of monoamine oxidase (MAO) in human blood platelets, plasma","volume":"80","author":"Bond","year":"1977","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.addr.2008.06.002_bib22","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/0006-2952(77)90398-7","article-title":"Substrate- and inhibitor-related characteristics of human platelet","volume":"26","author":"Donnelly","year":"1977","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.addr.2008.06.002_bib23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0306-4522(88)90250-3","article-title":"Localization of distinct monoamine oxidase A and monoamine oxidase B cell populations in human brainstem","volume":"25","author":"Westlund","year":"1988","journal-title":"Neuroscience"},{"key":"10.1016\/j.addr.2008.06.002_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0306-4522(94)90311-5","article-title":"Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography","volume":"62","author":"Saura","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.addr.2008.06.002_bib25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0165-3806(98)00013-3","article-title":"Differential expression of monoamine oxidase A, serotonin transporter, tyrosine hydroxylase and norepinephrine transporter mRNA by anorexia mutation and food deprivation","volume":"107","author":"Jahng","year":"1998","journal-title":"Develop. Brain Res."},{"key":"10.1016\/j.addr.2008.06.002_bib26","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1021\/jo50014a012","article-title":"Synthetic tuberculostats. V. Alkylidene derivatives of isonicotinylhydrazine","volume":"18","author":"Fox","year":"1953","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.addr.2008.06.002_bib27","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3181\/00379727-81-19910","article-title":"In vivo inhibition of liver and brain monoamine oxidase by 1-isonicotinyl-2-isopropyl hydrazine","volume":"81","author":"Zeller","year":"1952","journal-title":"Proc. Soc. Exp. Biol. NY"},{"key":"10.1016\/j.addr.2008.06.002_bib28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0165-1781(89)90003-6","article-title":"Blood platelet uptake of serotonin in episodic aggression","volume":"27","author":"Brown","year":"1989","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.addr.2008.06.002_bib29","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/0006-2952(91)90240-6","article-title":"Neurocatin-induced inhibition of monoamine oxidase A in rat brain synaptosomes","volume":"42","author":"Fernandez-Novoa","year":"1991","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.addr.2008.06.002_bib30","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0161-813X(03)00098-6","article-title":"Tribulin and endogenous mao-inhibitory regulation in vivo","volume":"25","author":"Medvedev","year":"2004","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.addr.2008.06.002_bib31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00004850-199300730-00001","article-title":"RIMA: a new concept in the treatment of depression with moclobemide","volume":"7","author":"Amrein","year":"1993","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.addr.2008.06.002_bib32","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3109\/00048679209072051","article-title":"Monoamine oxidase inhibitors (MAOI) or reversible inhibitors of monoamine oxidase (RIMA)\/tricyclic antidepressant (TCA) combination therapy","volume":"26","author":"Tiller","year":"1992","journal-title":"Aust. NZ J. Psychiatry"},{"key":"10.1016\/j.addr.2008.06.002_bib33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jad.2005.06.011","article-title":"MAOI efficacy and safety in advanced stage treatment-resistant depression: a retrospective study","volume":"89","author":"Amsterdam","year":"2005","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.addr.2008.06.002_bib34","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1192\/bjp.151.5.639","article-title":"Double-blind study of imipramine versus phenelzine in melancholias and dysthymic disorders","volume":"151","author":"Vallejo","year":"1987","journal-title":"Br. J. Psychiatry"},{"issue":"Suppl 18","key":"10.1016\/j.addr.2008.06.002_bib35","first-page":"5","article-title":"Course and treatment of atypical depression","volume":"59","author":"Nierenberg","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.addr.2008.06.002_bib36","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1345\/aph.19120","article-title":"Treatment for posttraumatic stress disorder","volume":"34","author":"Cyr","year":"2000","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.addr.2008.06.002_bib37","first-page":"131","article-title":"Monoamine oxidase inhibitors in obsessive\u2013compulsive disorder","volume":"44","author":"Jenike","year":"1983","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.addr.2008.06.002_bib38","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1001\/archneur.1993.00540030052014","article-title":"Deprenyl in attention deficit associated with Tourette's syndrome","volume":"50","author":"Jankovic","year":"1993","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.addr.2008.06.002_bib39","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1212\/WNL.46.4.965","article-title":"A controlled trial of deprenyl in children with Tourette's syndrome and attention deficit hyperactivity disorder","volume":"46","author":"Feigin","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.addr.2008.06.002_bib40","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0278-5846(03)00117-9","article-title":"Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial","volume":"27","author":"Akhondzadeh","year":"2003","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.addr.2008.06.002_bib41","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1089\/cap.2006.16.404","article-title":"Placebo-controlled study examining effects of selegiline in children with attention-deficit\/hyperactivity disorder","volume":"16","author":"Rubinstein","year":"2006","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.addr.2008.06.002_bib42","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1017\/S1461145799001522","article-title":"Does phenylethylamine act as an endogenous amphetamine in some patients?","volume":"2","author":"Janssen","year":"1999","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.addr.2008.06.002_bib43","first-page":"171","article-title":"The new generation of monoamine oxidase inhibitors","volume":"38","author":"Cesura","year":"1992","journal-title":"Prog. Drug Res."},{"key":"10.1016\/j.addr.2008.06.002_bib44","first-page":"179","article-title":"(\u2212)Deprenyl (selegiline): past, present and future","volume":"8","author":"Knoll","year":"2000","journal-title":"Neurobiology (Bp.)"},{"key":"10.1016\/j.addr.2008.06.002_bib45","doi-asserted-by":"crossref","first-page":"e1616","DOI":"10.1371\/journal.pone.0001616","article-title":"MAO-B elevation in mouse brain astrocytes results in Parkinson's pathology","volume":"3","author":"Mallajosyula","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2008.06.002_bib46","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/jnr.20350","article-title":"Rasagiline: neurodegeneration, neuroprotection, and mitochondrial permeability transition","volume":"79","author":"Youdim","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.addr.2008.06.002_bib47","first-page":"CD000442","article-title":"Selegiline for Alzheimer's disease","volume":"1","author":"Birks","year":"2003","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.addr.2008.06.002_bib48","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1023\/A:1012364910091","article-title":"Behavioral characteristics of mice with genetic knockout of monoamine oxidase type A","volume":"31","author":"Popova","year":"2001","journal-title":"Neurosci. Behav. Physiol."},{"key":"10.1016\/j.addr.2008.06.002_bib49","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1126\/science.7792602","article-title":"Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA","volume":"268","author":"Cases","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.addr.2008.06.002_bib50","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/ng1097-206","article-title":"Increased stress response and beta-phenylethylamine in MAOB-deficient mice","volume":"17","author":"Grimsby","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.addr.2008.06.002_bib51","doi-asserted-by":"crossref","first-page":"39645","DOI":"10.1074\/jbc.M405550200","article-title":"A spontaneous point mutation produces monoamine oxidase A\/B knock-out mice with greatly elevated monoamines and anxiety-like behavior","volume":"279","author":"Chen","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2008.06.002_bib52","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0006-8993(99)01478-X","article-title":"Ketanserin and tetrabenazine abolish aggression in mice lacking monoamine oxidase A","volume":"835","author":"Shih","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.addr.2008.06.002_bib53","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0006-3223(02)01418-X","article-title":"Monoamine oxidase inhibition during brain development induces pathological aggressive behavior in mice","volume":"52","author":"Mejia","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.addr.2008.06.002_bib54","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.1073\/pnas.94.11.5929","article-title":"Selective enhancement of emotional, but not motor, learning in monoamine oxidase A-deficient mice","volume":"94","author":"Kim","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2008.06.002_bib55","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11055-006-0022-z","article-title":"Acquisition and extinction of a conditioned passive avoidance reflex in mice with genetic knockout of monoamine oxidase A","volume":"36","author":"Dubrovina","year":"2006","journal-title":"Neurosci. Behav. Physiol."},{"key":"10.1016\/j.addr.2008.06.002_bib56","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0022-3565(24)29424-6","article-title":"Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs","volume":"298","author":"Cryan","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2008.06.002_bib57","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0006-3223(98)00139-5","article-title":"The spectrum of behaviors influenced by serotonin","volume":"44","author":"Lucki","year":"1998","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.addr.2008.06.002_bib58","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/WNR.0b013e3282fd6e88","article-title":"Novel monoamine oxidase A knock out mice with human-like spontaneous mutation","volume":"19","author":"Scott","year":"2008","journal-title":"Neuroreport"},{"key":"10.1016\/j.addr.2008.06.002_bib59","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.psyneuen.2005.06.005","article-title":"MAO A knockout attenuates adrenocortical response to various kinds of stress","volume":"31","author":"Popova","year":"2006","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.addr.2008.06.002_bib60","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1126\/science.8211186","article-title":"Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A","volume":"262","author":"Brunner","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.addr.2008.06.002_bib61","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0896-6273(00)80048-3","article-title":"Lack of barrels in the somatosensory cortex of monoamine oxidase A-deficient mice: role of a serotonin excess during the critical period","volume":"16","author":"Cases","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.addr.2008.06.002_bib62","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1074\/jbc.M609830200","article-title":"Forebrain-specific expression of monoamine oxidase A reduces neurotransmitter levels, restores the brain structure, and rescues aggressive behavior in monoamine oxidase A-deficient mice","volume":"282","author":"Chen","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2008.06.002_bib63","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1601-1848.2004.00074.x","article-title":"MAO-B knockout mice exhibit deficient habituation of locomotor activity but normal nicotine intake","volume":"3","author":"Lee","year":"2004","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.addr.2008.06.002_bib64","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF00433804","article-title":"Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain","volume":"72","author":"Garrick","year":"1980","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.addr.2008.06.002_bib65","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1046\/j.1471-4159.1999.0730647.x","article-title":"Adaptive changes in postsynaptic dopamine receptors despite unaltered dopamine dynamics in mice lacking monoamine oxidase B","volume":"73","author":"Chen","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.addr.2008.06.002_bib66","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1124\/mol.60.6.1181","article-title":"Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor","volume":"60","author":"Bunzow","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.addr.2008.06.002_bib67","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1471-4159.2004.02501.x","article-title":"Mammalian central nervous system trace amines: pharmacologic amphetamines, physiologic neuromodulators","volume":"90","author":"Berry","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.addr.2008.06.002_bib68","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF00429541","article-title":"Behavioral and electrophysiological effects of phenylethanolamine and 2-phenylethylamine","volume":"42","author":"Sabelli","year":"1975","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.addr.2008.06.002_bib69","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0091-3057(77)90096-X","article-title":"Characteristics of beta-phenethylamine self-administration by dog","volume":"6","author":"Risner","year":"1977","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.addr.2008.06.002_bib70","series-title":"The Trace Amines: Comparative and Clinical Neurobiology","first-page":"157","article-title":"Brain trace amines: mapping studies and effects of mesencephalic lesions","author":"Juorio","year":"1988"},{"key":"10.1016\/j.addr.2008.06.002_bib71","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1124\/jpet.107.134247","article-title":"Beta-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: implication for modulatory roles of trace amines in brain","volume":"325","author":"Xie","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2008.06.002_bib72","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1601-183X.2006.00292.x","article-title":"The trace amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia","volume":"6","author":"Wolinsky","year":"2007","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.addr.2008.06.002_bib73","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/syn.20334","article-title":"Differential effects of chronic amphetamine and baclofen administration on camp levels and phosphorylation of CREB in distinct brain regions of wild type and monoamine oxidase B-deficient mice","volume":"60","author":"Yin","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.addr.2008.06.002_bib74","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0006-8993(99)01167-1","article-title":"Cerebral cortical blood flow maps are reorganized in MAOB-deficient mice","volume":"824","author":"Scremin","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.addr.2008.06.002_bib75","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1192\/bjp.142.5.508","article-title":"l-Deprenil, a selective monoamine oxidase type B inhibitor, in the treatment of depression: a double blind evaluation","volume":"142","author":"Mendlewicz","year":"1983","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.addr.2008.06.002_bib76","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00004714-198908000-00024","article-title":"A possible l-deprenyl induced hypertensive reaction","volume":"9","author":"McGrath","year":"1989","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.addr.2008.06.002_bib77","first-page":"182","article-title":"Differential efficacy of l-deprenyl, a selective MAO type-B inhibitor, in endogenous and nonendogenous depression","volume":"18","author":"Mann","year":"1992","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.addr.2008.06.002_bib78","first-page":"1","article-title":"Oxidative stress in psychiatric disorders: evidence base and therapeutic implications","volume":"21","author":"NG","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.addr.2008.06.002_bib79","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/jnnp.69.2.228","article-title":"Homocysteine, folate, methylation, and monoamine metabolism in depression","volume":"69","author":"Bottiglieri","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.addr.2008.06.002_bib80","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0165-1781(96)02783-7","article-title":"Indicators of immune activation in major depression","volume":"64","author":"Sluzewska","year":"1996","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.addr.2008.06.002_bib81","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-0-585-37970-8_2","article-title":"Major depression and activation of the inflammatory response system","volume":"461","author":"Maes","year":"1999","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.addr.2008.06.002_bib82","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1046\/j.1525-1373.1999.d01-140.x","article-title":"Antioxidants, oxidative stress, and degenerative neurological disorders","volume":"222","author":"Floyd","year":"1999","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.addr.2008.06.002_bib83","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/0306-4522(95)00108-U","article-title":"A detailed analysis of hydrogen peroxide-induced cell death in primary neuronal culture","volume":"67","author":"Whittemore","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.addr.2008.06.002_bib84","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.0924-2708.2004.00090.x","article-title":"The relationship between potency of oxidative stress and severity of depression","volume":"16","author":"Yanik","year":"2004","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.addr.2008.06.002_bib85","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0165-0327(00)00199-3","article-title":"Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments","volume":"64","author":"Bilici","year":"2001","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.addr.2008.06.002_bib86","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/hup.829","article-title":"Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative\u2013antioxidative systems","volume":"22","author":"Sarandol","year":"2007","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.addr.2008.06.002_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.psy.0000195780.37277.2a","article-title":"Increased serum levels of 8-hydroxy-2\u2032-deoxyguanosine in clinical depression","volume":"68","author":"Forlenza","year":"2006","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.addr.2008.06.002_bib88","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.pnpbp.2006.03.034","article-title":"Examination of free radical metabolism and antioxidant defence system elements in patients with obsessive\u2013compulsive disorder","volume":"30","author":"Ersan","year":"2006","journal-title":"Prog. Neuropsychopharmacol, Biol. Psychiatry"},{"key":"10.1016\/j.addr.2008.06.002_bib89","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000063573","article-title":"Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive\u2013compulsive disorder","volume":"46","author":"Kuloglu","year":"2002","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.addr.2008.06.002_bib90","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000067810","article-title":"Antioxidant enzyme and malondialdehyde levels in patients with panic disorder","volume":"46","author":"Kuloglu","year":"2002","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.addr.2008.06.002_bib91","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00406-004-0484-3","article-title":"Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment","volume":"254","author":"Atmaca","year":"2004","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.addr.2008.06.002_bib92","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1749-6632.2001.tb05836.x","article-title":"Elevated nitric oxide\/peroxynitrite mechanism for the common etiology of multiple chemical sensitivity, chronic fatigue syndrome, and posttraumatic stress disorder","volume":"933","author":"Pall","year":"2001","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.addr.2008.06.002_bib93","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1006\/abbi.1996.0510","article-title":"The metabolism of tyramine by monoamine oxidase A\/B causes oxidative damage to mitochondrial DNA","volume":"335","author":"Hauptmann","year":"1996","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.addr.2008.06.002_bib94","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1023\/B:NERE.0000018845.82808.45","article-title":"Striatal damage and oxidative stress induced by the mitochondrial toxin malonate are reduced in clorgyline-treated rats and MAO-A deficient mice","volume":"29","author":"Maragos","year":"2004","journal-title":"Neurochem. Res."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X08001658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X08001658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T04:32:37Z","timestamp":1759206757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X08001658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":94,"journal-issue":{"issue":"13-14","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0169409X08001658"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2008.06.002","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monoamine oxidase inactivation: From pathophysiology to therapeutics","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2008.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}